Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Pathways' Picks

RFK Jr., Dr. Oz, UK Reforms, Generative AI, and More

In this week’s Pathways Picks: President-elect Donald Trump says he will nominate RFK Jr. as HHS secretary and Mehmet Oz as CMS administrator; Breakthrough Device Medicare coverage is introduced in the Senate; the UK government seeks more input on its pending medical device regulatory framework; Europe rolls out its orphan device pilot; FDA’s new Digital Health Advisory Committee meets to discuss generative AI; and FDA updates on emergency use authorization and ethylene oxide.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Start-Ups

MedTech Innovator at 10

Over the 10 years since Paul Grand created the medtech industry’s largest accelerator, it has helped start-ups launch many innovative medical products. We speak with the founders of ExplORer Surgical, BardyDx, and Pathology Watch about the role MedTech Innovator played in their successful exits.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More